This topic contains a solution. Click here to go to the answer

Author Question: Referencing use-case modeling, an external entity that interacts with the system best defines: A) ... (Read 48 times)

bb

  • Hero Member
  • *****
  • Posts: 544
Referencing use-case modeling, an external entity that interacts with the system best defines:
 
  A) player.
  B) actor.
  C) source.
  D) target.
  E) event.

Question 2

Inbound logistics involves receiving, storing, and disseminating inputs to products.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Gabe

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

B
Explanation: B) The actor, an external entity, initiates the start of a use case and starts the process in motion.
CL

Answer to Question 2

TRUE




bb

  • Member
  • Posts: 544
Reply 2 on: Jul 7, 2018
Great answer, keep it coming :)


laurnthompson

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Allergies play a major part in the health of children. The most prevalent childhood allergies are milk, egg, soy, wheat, peanuts, tree nuts, and seafood.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library